Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Post

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Pulmonary Circulation|January 20, 2025
Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal TreatmentD P Staal, F J van Leusden, M C J van Thor, et al.
The International Journal of Cardiovascular Imaging|February 22, 2022
Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertensionJ L Vos, T Leiner, A P J van Dijk, et al.
Orphanet Journal of Rare Diseases|August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaC L Shovlin, C M Millar, F Droege, et al.
Chest|May 13, 2026
Pretreatment with mono or dual PH-targeted medical therapy in patients undergoing balloon pulmonary angioplasty: effect on complications and clinical outcomesD P Staal, R Y Lely, A Breuning, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 17, 2020
ONCOR: design of the Dutch cardio-oncology registryJ A M Kamphuis, M Linschoten, M J Cramer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 30, 2019
Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the NetherlandsM C J van Thor, R J Lely, N J Braams, et al.
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 29, 2019
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trialJ J Brugts, J F Veenis, S P Radhoe, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Pulmonary Circulation|January 20, 2025
Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal TreatmentD P Staal, F J van Leusden, M C J van Thor, et al.
The International Journal of Cardiovascular Imaging|February 22, 2022
Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertensionJ L Vos, T Leiner, A P J van Dijk, et al.
Orphanet Journal of Rare Diseases|August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaC L Shovlin, C M Millar, F Droege, et al.
Chest|May 13, 2026
Pretreatment with mono or dual PH-targeted medical therapy in patients undergoing balloon pulmonary angioplasty: effect on complications and clinical outcomesD P Staal, R Y Lely, A Breuning, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 17, 2020
ONCOR: design of the Dutch cardio-oncology registryJ A M Kamphuis, M Linschoten, M J Cramer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 30, 2019
Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the NetherlandsM C J van Thor, R J Lely, N J Braams, et al.
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 29, 2019
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trialJ J Brugts, J F Veenis, S P Radhoe, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Pageof 7